EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
-27.87%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$172M
AUM Growth
+$172M
(-2.2%)
Cap. Flow
+$42.2M
Cap. Flow
% of AUM
24.52%
Top 10 Holdings %
Top 10 Hldgs %
98.6%
Holding
13
New
2
Increased
–
Reduced
1
Closed
2
Top Buys
| 1 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
$39.2M |
| 2 |
Coinbase
COIN
|
$8.91M |
Top Sells
| 1 |
Marqeta
MQ
|
$4.25M |
| 2 |
Vir Biotechnology
VIR
|
$1.69M |
| 3 |
Surrozen
SRZN
|
$3 |
Sector Composition
| 1 | Healthcare | 92.5% |
| 2 | Financials | 7.5% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PMV Pharmaceuticals
PMVP
$74.2M
| $48.7M | 28.27% |
2,336,909
| – | – |
|
|
ME
2
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $39.2M | 22.8% |
+10,243,122
| New | +$39.2M |
|
3
Foghorn Therapeutics
FHTX
$286M
| $19.2M | 11.16% |
1,261,261
| – | – |
|
4
Alector
ALEC
$238M
| $14M | 8.12% |
980,894
| – | – |
|
|
NGM
5
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $11.4M | 6.62% |
746,674
| – | – |
|
6
Tenaya Therapeutics
TNYA
$184M
| $10.8M | 6.27% |
915,705
| – | – |
|
7
RAPT Therapeutics
RAPT
$188M
| $9.52M | 5.53% |
432,900
| – | – |
|
|
8
Coinbase
COIN
$78.2B
| $8.91M | 5.18% |
+46,922
| New | +$8.91M |
|
9
First Financial Bancorp
FFBC
$2.51B
| $4M | 2.33% |
173,576
| – | – |
|
10
Oric Pharmaceuticals
ORIC
$994M
| $3.99M | 2.32% |
747,550
| – | – |
|
|
11
Surrozen
SRZN
$104M
| $2.42M | 1.4% |
802,963
-1
| -0% | -$3 |
|
|
12
Marqeta
MQ
$2.86B
| – | – |
-247,752
| Closed | -$4.25M |
|
|
13
Vir Biotechnology
VIR
$686M
| – | – |
-40,257
| Closed | -$1.69M |
|